US Stock MarketDetailed Quotes

SBFM Sunshine Biopharma

Watchlist

2.6300
+0.0200+0.77%

Close Nov 12 16:00 ET

2.6500
+0.0200+0.76%

Post 20:01 ET

5.26MMarket Cap-20P/E (TTM)

Sunshine Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-197.61%-1.36M

-21.17%-4.58M

-72.16%-3.19M

-67.20%-8.78M

-19.72%-2.69M

59.31%-457.29K

-558.42%-3.78M

-41.86%-1.85M

-186.93%-5.25M

-619.81%-2.25M

Net income from continuing operations

-83.86%-1.2M

45.21%-494.3K

24.59%-1.28M

83.15%-4.51M

94.68%-1.25M

55.29%-651.48K

-67.41%-902.11K

-37.71%-1.7M

-115.05%-26.74M

-3,624.47%-23.51M

Operating gains losses

----

-99.99%548

101.23%11.36K

Depreciation and amortization

73.75%64.63K

45.84%50.88K

22.78%42.62K

492.72%149.15K

123.18%42.35K

4,614.83%37.2K

1,425.32%34.88K

1,016.08%34.71K

97.50%25.16K

496.01%18.98K

Other non cash items

--2.55M

---2.55M

--12K

----

-101.11%-10.85K

----

Change In working capital

-199.48%-2.78M

13.15%-1.59M

-972.44%-1.96M

-240.06%-4.42M

-150.78%-1.48M

-378.80%-926.8K

-6,835.93%-1.83M

-156.55%-182.39K

2,999.44%3.15M

3,808.96%2.92M

-Change in receivables

963.08%546.52K

-596.90%-1.33M

-494.63%-536.26K

-13.28%-594.14K

10.63%-475.66K

-3,166,200.00%-63.32K

---191.05K

1,648.02%135.89K

-8,816.80%-524.49K

-7,881.14%-532.26K

-Change in inventory

-273.01%-1.25M

-81.41%-848.85K

-403.28%-2.1M

-5,603.45%-2.37M

-652.94%-1.14M

-422.59%-335.87K

-1,709.73%-467.93K

-464.97%-417.32K

152.50%42.98K

702.72%206.97K

-Change in prepaid assets

704.92%524.2K

458.78%296.17K

-538.19%-568.98K

-125.52%-21.14K

-433.85%-269.12K

207.60%65.13K

633.77%53K

1,541.65%129.85K

408.59%82.85K

1,860.45%80.61K

-Change in payables and accrued expense

-337.55%-2.59M

124.38%297.58K

4,155.92%1.25M

-140.45%-1.44M

-87.14%406.84K

-257.84%-592.74K

-13,017.19%-1.22M

-869.24%-30.81K

61,045.43%3.55M

9,651.67%3.16M

Cash from discontinued investing activities

Operating cash flow

-197.61%-1.36M

-21.17%-4.58M

-72.16%-3.19M

-67.20%-8.78M

-19.72%-2.69M

59.31%-457.29K

-558.42%-3.78M

-41.86%-1.85M

-186.93%-5.25M

-619.81%-2.25M

Investing cash flow

Cash flow from continuing investing activities

-3,166.80%-578.37K

-108.96%-542.21K

-357.09%-668.74K

95.51%-656.15K

98.16%-269.23K

18.86K

-259.48K

-146.3K

-14.62M

Net PPE purchase and sale

-2,411.58%-485.85K

-124.16%-944.51K

-195.92%-31.87K

130.94%49.7K

359.53%416.81K

--21.02K

---421.36K

--33.23K

---160.6K

Net intangibles purchase and sale

-4,185.27%-92.52K

150.26%402.3K

-257.00%-636.87K

-535.81%-705.85K

-517.97%-686.04K

---2.16K

--160.75K

---178.4K

---111.02K

Net business purchase and sale

----

--0

----

---1.14K

---14.35M

----

Cash from discontinued investing activities

Investing cash flow

-3,166.80%-578.37K

-108.96%-542.21K

-357.09%-668.74K

95.51%-656.15K

98.16%-269.23K

--18.86K

---259.48K

---146.3K

---14.62M

Financing cash flow

Cash flow from continuing financing activities

3,035.46%1.87M

-100.70%-28.58K

1,102.82%5.4M

-91.32%3.43M

98.54%-30.52K

-63.57K

-86.07%4.06M

-104.33%-538.3K

1,258.68%39.47M

-8,758.42%-2.1M

Net issuance payments of debt

-1.38%-29.66K

11.76%-28.58K

5.93%-29.61K

93.48%-125.99K

-2.95%-32.87K

---29.26K

---32.39K

98.34%-31.48K

-166.51%-1.93M

-100.95%-31.92K

Net common stock issuance

--0

1,162.06%5.38M

-88.28%3.55M

--0

---34.31K

-85.96%4.09M

-103.53%-506.82K

--30.27M

-297.56%-13.19M

Proceeds from stock option exercised by employees

--1.9M

--0

--45K

-99.97%3.5K

-99.98%2.35K

--0

--1.16K

--0

--13.19M

Net other financing activities

----

---2.06M

----

Cash from discontinued financing activities

Financing cash flow

3,035.46%1.87M

-100.70%-28.58K

1,102.82%5.4M

-91.32%3.43M

98.54%-30.52K

---63.57K

-86.07%4.06M

-104.33%-538.3K

1,258.68%39.47M

-8,758.42%-2.1M

Net cash flow

Beginning cash position

-41.67%11.51M

-9.64%17.43M

-25.35%16.29M

967.22%21.83M

-53.53%18.85M

-52.72%19.73M

46.42%19.29M

967.22%21.83M

106.61%2.05M

1,599.31%40.56M

Current changes in cash

85.38%-73.37K

-25,270.25%-5.15M

160.92%1.54M

-130.65%-6.01M

84.23%-2.99M

55.33%-502K

-99.93%20.46K

-122.77%-2.53M

1,722.08%19.6M

-5,547.28%-18.96M

Effect of exchange rate changes

302.51%772.28K

-287.53%-777.89K

-16,266.85%-402.39K

156.42%471.58K

87.16%435.63K

-692.71%-381.36K

158,227.48%414.82K

347.17%2.49K

1,007.40%183.91K

4,209.53%232.76K

End cash Position

-35.23%12.21M

-41.67%11.51M

-9.64%17.43M

-25.35%16.29M

-53.53%18.85M

-52.72%19.73M

46.42%19.29M

967.22%21.83M

Free cash flow

-320.07%-1.97M

-26.47%-5.15M

-91.52%-3.88M

-72.21%-9.56M

-17.31%-2.99M

58.26%-469.08K

-609.70%-4.07M

-55.54%-2.03M

-203.61%-5.55M

-717.53%-2.55M

Currency Unit

USD

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-197.61%-1.36M	-21.17%-4.58M	-72.16%-3.19M	-67.20%-8.78M	-19.72%-2.69M	59.31%-457.29K	-558.42%-3.78M	-41.86%-1.85M	-186.93%-5.25M	-619.81%-2.25M
Net income from continuing operations	-83.86%-1.2M	45.21%-494.3K	24.59%-1.28M	83.15%-4.51M	94.68%-1.25M	55.29%-651.48K	-67.41%-902.11K	-37.71%-1.7M	-115.05%-26.74M	-3,624.47%-23.51M
Operating gains losses	----	----	----	----	----	----	----	----	-99.99%548	101.23%11.36K
Depreciation and amortization	73.75%64.63K	45.84%50.88K	22.78%42.62K	492.72%149.15K	123.18%42.35K	4,614.83%37.2K	1,425.32%34.88K	1,016.08%34.71K	97.50%25.16K	496.01%18.98K
Other non cash items	--2.55M	---2.55M	--12K	----	----	----	----	----	-101.11%-10.85K	----
Change In working capital	-199.48%-2.78M	13.15%-1.59M	-972.44%-1.96M	-240.06%-4.42M	-150.78%-1.48M	-378.80%-926.8K	-6,835.93%-1.83M	-156.55%-182.39K	2,999.44%3.15M	3,808.96%2.92M
-Change in receivables	963.08%546.52K	-596.90%-1.33M	-494.63%-536.26K	-13.28%-594.14K	10.63%-475.66K	-3,166,200.00%-63.32K	---191.05K	1,648.02%135.89K	-8,816.80%-524.49K	-7,881.14%-532.26K
-Change in inventory	-273.01%-1.25M	-81.41%-848.85K	-403.28%-2.1M	-5,603.45%-2.37M	-652.94%-1.14M	-422.59%-335.87K	-1,709.73%-467.93K	-464.97%-417.32K	152.50%42.98K	702.72%206.97K
-Change in prepaid assets	704.92%524.2K	458.78%296.17K	-538.19%-568.98K	-125.52%-21.14K	-433.85%-269.12K	207.60%65.13K	633.77%53K	1,541.65%129.85K	408.59%82.85K	1,860.45%80.61K
-Change in payables and accrued expense	-337.55%-2.59M	124.38%297.58K	4,155.92%1.25M	-140.45%-1.44M	-87.14%406.84K	-257.84%-592.74K	-13,017.19%-1.22M	-869.24%-30.81K	61,045.43%3.55M	9,651.67%3.16M
Cash from discontinued investing activities
Operating cash flow	-197.61%-1.36M	-21.17%-4.58M	-72.16%-3.19M	-67.20%-8.78M	-19.72%-2.69M	59.31%-457.29K	-558.42%-3.78M	-41.86%-1.85M	-186.93%-5.25M	-619.81%-2.25M
Investing cash flow
Cash flow from continuing investing activities	-3,166.80%-578.37K	-108.96%-542.21K	-357.09%-668.74K	95.51%-656.15K	98.16%-269.23K	18.86K	-259.48K	-146.3K	-14.62M	-14.62M
Net PPE purchase and sale	-2,411.58%-485.85K	-124.16%-944.51K	-195.92%-31.87K	130.94%49.7K	359.53%416.81K	--21.02K	---421.36K	--33.23K	---160.6K	---160.6K
Net intangibles purchase and sale	-4,185.27%-92.52K	150.26%402.3K	-257.00%-636.87K	-535.81%-705.85K	-517.97%-686.04K	---2.16K	--160.75K	---178.4K	---111.02K	---111.02K
Net business purchase and sale	----	----	--0	--0	----	----	----	---1.14K	---14.35M	----
Cash from discontinued investing activities
Investing cash flow	-3,166.80%-578.37K	-108.96%-542.21K	-357.09%-668.74K	95.51%-656.15K	98.16%-269.23K	--18.86K	---259.48K	---146.3K	---14.62M	---14.62M
Financing cash flow
Cash flow from continuing financing activities	3,035.46%1.87M	-100.70%-28.58K	1,102.82%5.4M	-91.32%3.43M	98.54%-30.52K	-63.57K	-86.07%4.06M	-104.33%-538.3K	1,258.68%39.47M	-8,758.42%-2.1M
Net issuance payments of debt	-1.38%-29.66K	11.76%-28.58K	5.93%-29.61K	93.48%-125.99K	-2.95%-32.87K	---29.26K	---32.39K	98.34%-31.48K	-166.51%-1.93M	-100.95%-31.92K
Net common stock issuance	--0	--0	1,162.06%5.38M	-88.28%3.55M	--0	---34.31K	-85.96%4.09M	-103.53%-506.82K	--30.27M	-297.56%-13.19M
Proceeds from stock option exercised by employees	--1.9M	--0	--45K	-99.97%3.5K	-99.98%2.35K	--0	--1.16K	--0	--13.19M	--13.19M
Net other financing activities	----	----	----	----	----	----	----	----	---2.06M	----
Cash from discontinued financing activities
Financing cash flow	3,035.46%1.87M	-100.70%-28.58K	1,102.82%5.4M	-91.32%3.43M	98.54%-30.52K	---63.57K	-86.07%4.06M	-104.33%-538.3K	1,258.68%39.47M	-8,758.42%-2.1M
Net cash flow
Beginning cash position	-41.67%11.51M	-9.64%17.43M	-25.35%16.29M	967.22%21.83M	-53.53%18.85M	-52.72%19.73M	46.42%19.29M	967.22%21.83M	106.61%2.05M	1,599.31%40.56M
Current changes in cash	85.38%-73.37K	-25,270.25%-5.15M	160.92%1.54M	-130.65%-6.01M	84.23%-2.99M	55.33%-502K	-99.93%20.46K	-122.77%-2.53M	1,722.08%19.6M	-5,547.28%-18.96M
Effect of exchange rate changes	302.51%772.28K	-287.53%-777.89K	-16,266.85%-402.39K	156.42%471.58K	87.16%435.63K	-692.71%-381.36K	158,227.48%414.82K	347.17%2.49K	1,007.40%183.91K	4,209.53%232.76K
End cash Position	-35.23%12.21M	-41.67%11.51M	-9.64%17.43M	-25.35%16.29M	-25.35%16.29M	-53.53%18.85M	-52.72%19.73M	46.42%19.29M	967.22%21.83M	967.22%21.83M
Free cash flow	-320.07%-1.97M	-26.47%-5.15M	-91.52%-3.88M	-72.21%-9.56M	-17.31%-2.99M	58.26%-469.08K	-609.70%-4.07M	-55.54%-2.03M	-203.61%-5.55M	-717.53%-2.55M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data